
Telpro Max5 mg+80 mg
Renata Limited
Amlodipine Besilate + Telmisartan is a fixed-dose combination of a dihydropyridine calcium channel blocker (amlodipine) and an angiotensin II receptor blocker (telmisartan) and more.
Amlodipine Besilate + Telmisartan is a fixed-dose combination of a dihydropyridine calcium channel blocker (amlodipine) and an angiotensin II receptor blocker (telmisartan), indicated for:
Amlodipine Besilate + Telmisartan is not indicated as initial therapy in patients 75 years of age or older, or in patients with hepatic impairment; in these groups, the individual components should be titrated separately first.
| Clinical Scenario | Recommended Dose |
|---|---|
| Usual starting dose | 40 mg telmisartan/5 mg amlodipine once daily |
| Patients needing greater blood pressure reduction | 80 mg telmisartan/5 mg amlodipine once daily |
| Dose titration (after ≥2 weeks if BP not controlled) | May increase up to a maximum of 80 mg/10 mg once daily |
| Maximum dose | 80 mg telmisartan/10 mg amlodipine once daily |
Amlodipine Besilate + Telmisartan may be taken with or without food, at approximately the same time each day. Swallow the tablet whole; do not remove it from the blister pack until immediately before use.
Most of the antihypertensive effect is seen within 2 weeks, with the maximal effect generally achieved by about 4 weeks of therapy.
Most patients tolerate Amlodipine Besilate + Telmisartan well. Reported adverse effects include:
Report any persistent, severe, or unusual side effect to your physician.
Amlodipine Besilate + Telmisartan is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.